Your session is about to expire
← Back to Search
Cleft Palate Repair for Cleft Palate
Study Summary
This trial is testing whether earlier repair of cleft palate leads to better speech development, velopharyngeal functioning, and facial growth outcomes, compared to the Hospital for Sick Children's routine repair.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You were born with a condition called Pierre Robin sequence.The baby has a gap in the roof of their mouth that has not been repaired and is not related to any other medical condition.If your cleft lip and/or palate only affects the front portion of your mouth or the roof of your mouth.The child has both a cleft lip and palate.You have symptoms or a medical condition that suggest you may have a related syndrome.
- Group 1: Group A
- Group 2: Group B
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any available positions left for participants in this clinical trial?
"This study is no longer recruiting participants, according to the clinicaltrials.gov website. The trial was originally posted on 4/1/2008, and the most recent update was on 3/23/2022. There are 12 other similar trials enrolling patients at this time."
Can people who are younger than 50 years old join this clinical trial?
"According to the information available, the age limit for this trial is 5 months old. If the patient is a minor, then there are 12 different trials they could be eligible for. If the patient is over 65, then there are 2 trials they could be eligible for."
Share this study with friends
Copy Link
Messenger